About: Noxxon Pharma

An Entity of Type: Aktiengesellschaft, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Noxxon Pharma is a biotechnology company founded in 1997 in Berlin, Germany and is focused on improving cancer treatment by targeting the tumor microenvironment. Noxxon Pharma N.V. is listed on Euronext Growth, Paris (ALNOX). The company is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller (vfa). The L-RNA are resistant to the natural RNA nuclease enzymes.

Property Value
dbo:abstract
  • Noxxon Pharma is a biotechnology company founded in 1997 in Berlin, Germany and is focused on improving cancer treatment by targeting the tumor microenvironment. Noxxon Pharma N.V. is listed on Euronext Growth, Paris (ALNOX). The company is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller (vfa). Noxxon Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to natural occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror." The L-RNA are resistant to the natural RNA nuclease enzymes. (en)
dbo:foundingYear
  • 1997-01-01 (xsd:gYear)
dbo:location
dbo:numberOfEmployees
  • 10 (xsd:nonNegativeInteger)
dbo:thumbnail
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 39945332 (xsd:integer)
dbo:wikiPageLength
  • 5455 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1110582287 (xsd:integer)
dbo:wikiPageWikiLink
dbp:foundation
  • 1997 (xsd:integer)
dbp:homepage
dbp:keyPeople
  • * Aram Mangasarian, CEO * Maurizio PetitBon, Chairman of the supervisory board * Jens P. Furste, Founder (en)
dbp:location
dbp:logo
  • NOXXON logo HD2.png (en)
dbp:name
  • Noxxon Pharma (en)
dbp:numEmployees
  • 10 (xsd:integer)
dbp:type
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Noxxon Pharma is a biotechnology company founded in 1997 in Berlin, Germany and is focused on improving cancer treatment by targeting the tumor microenvironment. Noxxon Pharma N.V. is listed on Euronext Growth, Paris (ALNOX). The company is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller (vfa). The L-RNA are resistant to the natural RNA nuclease enzymes. (en)
rdfs:label
  • Noxxon Pharma (en)
owl:sameAs
skos:closeMatch
prov:wasDerivedFrom
foaf:depiction
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Noxxon Pharma (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License